BioVaxys Technology Statistics

Total Valuation

CSE:BIOV has a market cap or net worth of CAD 16.03 million. The enterprise value is 15.89 million.

Market Cap	16.03M
Enterprise Value	15.89M

Important Dates

The next estimated earnings date is Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:BIOV has 291.53 million shares outstanding. The number of shares has increased by 45.90% in one year.

Current Share Class	n/a
Shares Outstanding	291.53M
Shares Change (YoY)	+45.90%
Shares Change (QoQ)	+10.22%
Owned by Insiders (%)	12.16%
Owned by Institutions (%)	n/a
Float	256.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-275.96%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	162.60%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.33% in the last 52 weeks. The beta is -0.15, so CSE:BIOV's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	-33.33%
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	47.79
Average Volume (20 Days)	87,964

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.12M
Pretax Income	-3.95M
Net Income	-3.95M
EBITDA	n/a
EBIT	-3.12M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 211,806 in cash and 68,080 in debt, giving a net cash position of 143,726 or 0.00 per share.

Cash & Cash Equivalents	211,806
Total Debt	68,080
Net Cash	143,726
Net Cash Per Share	0.00
Equity (Book Value)	-1.92M
Book Value Per Share	-0.01
Working Capital	-1.92M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.86M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BIOV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.90%
Shareholder Yield	-45.90%
Earnings Yield	-24.67%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a